innovate advance engage educate
Maximized engagement. Maximized impact.
Paradigm Medical Communications delivers award-winning medical education designed to advance clinical knowledge and enhance patient care.
Through innovation, scientific rigor, and continuous refinement, we create evidence-based programs that engage diverse healthcare audiences and drive measurable outcomes and lasting impact.
CME Spotlight
Program Overview
View this engaging on-demand webinar, filmed live during 2025 Aesthetic Extenders Symposium (AES).
CME Spotlight
Program Overview
Join this virtual case-based CME activity that explores IDH and FLT3 mutations and how they influence prognosis and guide targeted therapy decisions in patients with acute myeloid leukemia (AML). Our expert faculty will discuss clinical data supporting IDH1/2 inhibitors and FLT3-targeted agents and review treatment sequencing, resistance patterns, and integration of novel therapies into practice. The conversation will also take a deep dive into precision medicine and evidence-based care strategies to treat patients with AML who have these actionable mutations.
In Collaboration With:
CME Spotlight
Program Overview
This dynamic CME program blends interactive case consultations with a data-driven deep dive into long-acting injectables (LAIs) for schizophrenia. Through engaging real-world scenarios, learners will explore barriers and biases that influence LAI utilization and discover communication strategies that foster shared decision-making with patients and caregivers. A comprehensive evidence review highlights innovative LAIs, their attributes, and the latest clinical trial findings, offering practical insights for treatment planning. This unique format equips clinicians with both the knowledge and the skills to optimize adherence, improve outcomes, and confidently integrate LAIs into patient care.
CME Spotlight
Program Overview
This interactive infographic will focus on the pathophysiology of Sjögren’s disease (SjD), supporting the rationale for the mechanisms of action of emerging targeted B-cell treatments in SjD and clinical data. This will include discussions of trial designs and outcomes measured, including impact on quality of life. The faculty discussions will reflect on treatment targets and highlight potential clinical applications of emerging agents.
This activity is jointly provided by Paradigm Medical Communications, LLC and Educational Review Systems, Inc.
In collaboration with Sjögren’s Foundation.
CME Spotlight
Program Overview
New treatment options such as anti-vascular endothelial growth factor (VEGF) therapies and advances in imaging technologies have changed the standard of care for retinal vein occlusion (RVO). What anti-VEGF agents are recommended as first-line therapy for RVO? Are the anti-VEGF agents successful in treating macular edema secondary to RVO?
Join Dr Katherine Talcott as she discusses the most up-to-date facts about who is diagnosed with RVO and what options are recommended by the American Academy of Ophthalmology Preferred Practice Pattern to treat macular edema secondary to RVO.
CME Spotlight
Program Overview
Despite an expanding array of advanced therapies for IBD, many patients with moderate to severe disease remain refractory to current options. Anti- tumor necrosis factor-like ligand 1A (TL1A) agents represent a promising new class targeting TL1A, a cytokine implicated in IBD pathogenesis. Experts review the current landscape and contextualize emerging data that suggest TL1A blockade may deliver meaningful clinical outcomes. As late-phase trials progress, clinicians should stay informed on this novel mechanism of action and its potential role in personalized treatment strategies for IBD.
CME Spotlight
Program Overview
This American Academy of Ophthalmology collection focuses on the changing approaches to treating glaucoma.
These CME activities feature our expert faculty providing insights on guideline-based care, the use of clinical trial data to explore new glaucoma treatments, and how to tailor glaucoma care to individual patients.
CME Spotlight
Program Overview
The Eye-Connect Learning Center is an educational resource developed by Paradigm Medical Communications. The Learning Center, which features multiple individually accredited CE activities and patient and clinician resources, is for educational purposes only. Healthcare professionals are expected to employ their own knowledge and judgement during any discussion with, or treatment of, their patients.
Our Educational Design Process Puts Us Ahead
Practice gaps, educational needs, target audiences, desired outcomes.
Learning objectives, educational formats, timely content, assessment strategies.
Tailored learning plans to put education into action.
Feedback and data from multiple sources throughout the life cycle of the initiative.
Recognized By
Throughout its more than 20-year history of providing quality continuing education for healthcare professionals, Paradigm has been the proud recipient of numerous awards from various professional organizations concerned with innovation and improvement in the CME field.
